PT Pyridam Farma Tbk (PYFA.JK)
IDR 212.0
(0.95%)
IDR 212.0
(0.95%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 702.06 Billion IDR | -1.87% |
| 2022 | 715.42 Billion IDR | 13.46% |
| 2021 | 630.53 Billion IDR | 127.3% |
| 2020 | 277.39 Billion IDR | 12.25% |
| 2019 | 247.11 Billion IDR | -1.33% |
| 2018 | 250.44 Billion IDR | 12.31% |
| 2017 | 223 Billion IDR | 2.79% |
| 2016 | 216.95 Billion IDR | -0.41% |
| 2015 | 217.84 Billion IDR | -2.01% |
| 2014 | 222.3 Billion IDR | 15.45% |
| 2013 | 192.55 Billion IDR | 8.95% |
| 2012 | 176.73 Billion IDR | 16.97% |
| 2011 | 151.09 Billion IDR | 7.27% |
| 2010 | 140.85 Billion IDR | 6.71% |
| 2009 | 132 Billion IDR | 10.39% |
| 2008 | 119.58 Billion IDR | 38.02% |
| 2007 | 86.64 Billion IDR | 41.26% |
| 2006 | 61.33 Billion IDR | 54.74% |
| 2005 | 39.63 Billion IDR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 255.68 Billion IDR | 68.62% |
| 2024 Q3 | 754.5 Billion IDR | 195.09% |
| 2024 Q1 | 151.63 Billion IDR | -16.5% |
| 2023 Q4 | 181.59 Billion IDR | -12.21% |
| 2023 Q2 | 148.75 Billion IDR | -9.77% |
| 2023 Q3 | 206.86 Billion IDR | 39.06% |
| 2023 Q1 | 164.86 Billion IDR | 0.22% |
| 2023 FY | 702.06 Billion IDR | -1.87% |
| 2022 Q2 | 134.66 Billion IDR | -21.9% |
| 2022 Q4 | 164.5 Billion IDR | -32.53% |
| 2022 FY | 715.42 Billion IDR | 13.46% |
| 2022 Q1 | 172.44 Billion IDR | -23.07% |
| 2022 Q3 | 243.81 Billion IDR | 81.04% |
| 2021 Q4 | 224.15 Billion IDR | 21.91% |
| 2021 Q2 | 105.09 Billion IDR | -10.49% |
| 2021 Q1 | 117.41 Billion IDR | 42.98% |
| 2021 Q3 | 183.86 Billion IDR | 74.95% |
| 2021 FY | 630.53 Billion IDR | 127.3% |
| 2020 Q2 | 42.53 Billion IDR | -46.18% |
| 2020 FY | 277.39 Billion IDR | 12.25% |
| 2020 Q4 | 82.12 Billion IDR | 11.42% |
| 2020 Q3 | 73.7 Billion IDR | 73.28% |
| 2020 Q1 | 79.03 Billion IDR | 26.67% |
| 2019 Q1 | 63.81 Billion IDR | -1.7% |
| 2019 FY | 247.11 Billion IDR | -1.33% |
| 2019 Q4 | 62.39 Billion IDR | -1.51% |
| 2019 Q3 | 63.35 Billion IDR | 10.09% |
| 2019 Q2 | 57.54 Billion IDR | -9.83% |
| 2018 FY | 250.44 Billion IDR | 12.31% |
| 2018 Q4 | 64.92 Billion IDR | 3.68% |
| 2018 Q3 | 62.62 Billion IDR | 7.9% |
| 2018 Q2 | 58.03 Billion IDR | -10.52% |
| 2018 Q1 | 64.86 Billion IDR | 18.78% |
| 2017 Q2 | 54.71 Billion IDR | 5.38% |
| 2017 Q1 | 51.91 Billion IDR | -8.75% |
| 2017 Q3 | 61.76 Billion IDR | 12.88% |
| 2017 FY | 223 Billion IDR | 2.79% |
| 2017 Q4 | 54.6 Billion IDR | -11.58% |
| 2016 Q3 | 46.6 Billion IDR | -22.91% |
| 2016 Q4 | 56.89 Billion IDR | 22.09% |
| 2016 FY | 216.95 Billion IDR | -0.41% |
| 2016 Q2 | 60.45 Billion IDR | 14.06% |
| 2016 Q1 | 52.99 Billion IDR | -7.57% |
| 2015 Q4 | 57.33 Billion IDR | 12.15% |
| 2015 FY | 217.84 Billion IDR | -2.01% |
| 2015 Q2 | 53.55 Billion IDR | -4.08% |
| 2015 Q1 | 55.82 Billion IDR | -6.28% |
| 2015 Q3 | 51.12 Billion IDR | -4.53% |
| 2014 FY | 222.3 Billion IDR | 15.45% |
| 2014 Q1 | 56.91 Billion IDR | 1.35% |
| 2014 Q2 | 50.15 Billion IDR | -11.88% |
| 2014 Q4 | 59.56 Billion IDR | 7.02% |
| 2014 Q3 | 55.65 Billion IDR | 10.96% |
| 2013 Q4 | 56.15 Billion IDR | 3.86% |
| 2013 Q2 | 36.35 Billion IDR | -20.92% |
| 2013 Q1 | 45.96 Billion IDR | -6.08% |
| 2013 FY | 192.55 Billion IDR | 8.95% |
| 2013 Q3 | 54.07 Billion IDR | 48.75% |
| 2012 Q1 | 47.77 Billion IDR | 24.27% |
| 2012 FY | 176.73 Billion IDR | 16.97% |
| 2012 Q3 | 38.78 Billion IDR | -5.95% |
| 2012 Q4 | 48.94 Billion IDR | 26.21% |
| 2012 Q2 | 41.23 Billion IDR | -13.69% |
| 2011 Q2 | 36.17 Billion IDR | -8.75% |
| 2011 Q4 | 38.44 Billion IDR | 4.35% |
| 2011 Q1 | 39.63 Billion IDR | 0.0% |
| 2011 Q3 | 36.83 Billion IDR | 1.85% |
| 2011 FY | 151.09 Billion IDR | 7.27% |
| 2010 FY | 140.85 Billion IDR | 6.71% |
| 2009 FY | 132 Billion IDR | 10.39% |
| 2008 FY | 119.58 Billion IDR | 38.02% |
| 2007 FY | 86.64 Billion IDR | 41.26% |
| 2006 FY | 61.33 Billion IDR | 54.74% |
| 2005 FY | 39.63 Billion IDR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 1890.88 Billion IDR | 62.871% |
| PT Merck Tbk | 961.43 Billion IDR | 26.977% |
| PT Phapros, Tbk | 1014.12 Billion IDR | 30.771% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 3565.93 Billion IDR | 80.312% |
| PT Tempo Scan Pacific Tbk | 13119.78 Billion IDR | 94.649% |